9 results match your criteria: "Hungary. reusz.gyorgy@med.semmelweis-univ.hu.[Affiliation]"
Pediatr Nephrol
August 2023
1st Department of Pediatrics, Semmelweis University, 53-54 Bókay János Street, 1083, Budapest, Hungary.
Pediatr Nephrol
August 2023
1st Department of Pediatrics, Semmelweis University, 53-54 Bókay János Street, Budapest, 1083, Hungary.
Given the wide diversity of causes of hematuria, ranging from simple urinary tract infections with rapid recovery to severe glomerulonephritis with fast decline in kidney function, it is essential to recognize the underlying disease. The first objective of the assessment is to determine whether the cause of the hematuria is medically significant. The combination of hematuria with proteinuria, the presence of hypertension, or worsening kidney function can represent signs of progressive kidney disease.
View Article and Find Full Text PDFPediatr Nephrol
June 2022
Pediatric Hematology and Stem Cell Transplantation Unit, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary.
Pediatr Nephrol
October 2022
1st Department of Pediatrics, Semmelweis University, Bókay János Str. 53-54, Budapest, 1083, Hungary.
Background: Kidney transplantation (KTx) improves prognosis in children with kidney failure; still, these patients are prone to cardiovascular damage due to multiple risk factors. Our aim was to assess myocardial structure and function in pediatric KTx by conventional and speckle-tracking echocardiography (STE) in association with established cardiovascular risk factors.
Methods: Forty-two KTx and 39 healthy age- and gender-matched children were evaluated.
Pediatr Nephrol
May 2022
Pediatric Hematology and Stem Cell Transplantation Unit, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary.
Pediatr Nephrol
May 2022
Pediatric Hematology and Stem Cell Transplantation Unit, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary.
Pediatr Nephrol
October 2021
First Department of Pediatrics, Semmelweis University, HU, 1083, Budapest, Hungary.
Ital J Pediatr
December 2014
3rd Department of Internal Medicine, Semmelweis University, Kútvölgyi st. 4, H-1125, Budapest, Hungary.
Background: Atypical hemolytic uremic syndrome (aHUS) is a rare and heterogeneous disorder. The first line treatment of aHUS is plasma therapy, but in the past few years, the recommendations have changed greatly with the advent of eculizumab, a humanized monoclonal anti C5-antibody. Although recent recommendations suggest using it as a primary treatment for aHUS, important questions have arisen about the necessity of immediate use of eculizumab in all cases.
View Article and Find Full Text PDF